Page last updated: 2024-09-03

3-(2,4-dimethoxybenzylidene)anabaseine and Endotoxemia

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Endotoxemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhakdisongkhram, S; Brenner, T; Hofer, S; Motsch, J; Philipsenburg, C; Schmidt, K; Uhle, F; Weigand, MA; Zivkovic, AR1
Gordinou de Gouberville, MC; Hoedemaekers, CW; Kox, M; Pickkers, P; Pompe, JC; van der Hoeven, JG1
Ulloa, L1
Al-Abed, Y; Czura, CJ; Gallowitsch-Puerta, M; Larosa, GJ; Levi, J; Lin, X; Miller, EJ; Ochani, K; Ochani, M; Parrish, WR; Pavlov, VA; Rosas-Ballina, M; Tracey, KJ; Yang, LH1
Bojalil, R1

Trials

1 trial(s) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Endotoxemia

ArticleYear
Effects of the α7 nicotinic acetylcholine receptor agonist GTS-21 on the innate immune response in humans.
    Shock (Augusta, Ga.), 2011, Volume: 36, Issue:1

    Topics: Adolescent; Adult; alpha7 Nicotinic Acetylcholine Receptor; Anti-Inflammatory Agents; Benzylidene Compounds; Endotoxemia; Hemodynamics; Humans; Immunity, Innate; Interleukin 1 Receptor Antagonist Protein; Interleukin-10; Interleukin-6; Lipopolysaccharides; Male; Nicotinic Agonists; Pyridines; Receptors, Nicotinic; Tumor Necrosis Factor-alpha; Young Adult

2011

Other Studies

4 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Endotoxemia

ArticleYear
GTS-21 reduces microvascular permeability during experimental endotoxemia.
    Microvascular research, 2018, Volume: 115

    Topics: Animals; Benzylidene Compounds; Capillary Permeability; Disease Models, Animal; Endotoxemia; Intravital Microscopy; Lipopolysaccharides; Male; Mesentery; Microvessels; Nicotinic Agonists; Pyridines; Rats, Wistar; Time Factors; Tumor Necrosis Factor-alpha

2018
The anti-inflammatory potential of selective cholinergic agonists.
    Shock (Augusta, Ga.), 2011, Volume: 36, Issue:1

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Anti-Inflammatory Agents; Benzylidene Compounds; Endotoxemia; Humans; Immunity, Innate; Male; Nicotinic Agonists; Pyridines; Receptors, Nicotinic

2011
Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.
    Critical care medicine, 2007, Volume: 35, Issue:4

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Cell Line; Dose-Response Relationship, Drug; Endotoxemia; HMGB1 Protein; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Nicotinic Agonists; Pyridines; Receptors, Nicotinic; Sepsis; Severity of Illness Index; Survival Rate; Tumor Necrosis Factor-alpha

2007
Are we finally taming inflammation?
    Critical care medicine, 2007, Volume: 35, Issue:4

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Dose-Response Relationship, Drug; Endotoxemia; HMGB1 Protein; Inflammation; Mice; NF-kappa B; Nicotinic Agonists; Pyridines; Receptors, Nicotinic; Sepsis; Severity of Illness Index; Tumor Necrosis Factor-alpha

2007